[Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice]

MeSH terms

• Algorithms
• Anti-Infective Agents / therapeutic use*
• Humans
• Multiple Organ Failure / drug therapy*
• Multiple Organ Failure / etiology*
• Patient Selection*
• Protein C / therapeutic use*
• Randomized Controlled Trials as Topic
• Recombinant Proteins / therapeutic use*
• Risk Assessment
• Sepsis / complications*
• Sepsis / drug therapy*
• Severity of Illness Index